FDA warns GLP-1 drugs may pose risk of rare vision loss condition

The FDA has issued a warning that GLP-1 drugs may carry a small risk of a rare condition that can cause vision loss. Although the data on this risk is mixed, the FDA emphasizes the importance of patient awareness regarding this potential side effect.

Originally published by arstechnica